Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

InSite Vision Inc

+ Add to Watchlist

INSV:US

0.1870 USD 0.0010 0.53%

As of 20:10:03 ET on 03/27/2015.

Company Profile for InSite Vision Inc (INSV)

InSite Vision Incorporated develops ophthalmic pharmaceutical products based on its DuraSite drug delivery technology. The Company also develops genetically based tools for the diagnosis and prognosis of glaucoma. InSite's products are intended to address a broad spectrum of ocular indications, including glaucoma, inflammation, and infection.

Contact Information

InSite Vision Inc

965 Atlantic Avenue
Alameda, CA 94501
United States
Phone: 1-510-865-8800
Fax: 1-510-865-5700

Key Executives for InSite Vision Inc (INSV)

Timothy M RuaneChief Executive OfficerLouis C DrapeauVP/CFO
Kamran HosseiniVP:Clinical & RegulatoryLyle M BowmanVP:Development/Secretary
Surendra PatelVP:Operations & Quality

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil